Recurrent giant neurofibroma of the posterior neck and upper back with failed primary grafting and salvage reconstruction: a case report
Abstract
Background: Giant or recurrent neurofibromas associated with neurofibromatosis type 1 (NF1) may mimic vascular tumors and create large reconstructive defects, particularly in mobile regions. We report a recurrent posterior neck and upper-back neurofibroma with failure of primary grafting and subsequent salvage reconstruction.
Case presentation: A 23-year-old woman had previously undergone an aborted operation for a lesion diagnosed as hemangioma; postoperative pathology showed neurofibroma. The recurrent mass was excised along the superficial aspect of the deep fascia with an estimated blood loss of approximately 100 mL, leaving a defect involving about 7% of total body surface area. A split-thickness graft harvested from clinically preserved skin overlying the tumor failed after subgraft seroma formation and Klebsiella pneumoniae infection, with approximately 20% graft take. Salvage treatment consisted of repeat debridement, culture-directed infection control, a 1:3 meshed split-thickness graft from the thigh, negative-pressure wound therapy adapted into separate neck and back dressing zones, and postoperative immobilization. Graft take was complete. At 6 months, no recurrence was detected, neck motion was preserved, the Vancouver Scar Scale score was 3, and the Neck Disability Index score was 5.
Conclusions: This case emphasizes accurate diagnosis, careful selection of graft donor skin, adequate wound-bed preparation, infection control, secure graft fixation, and…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.